Insider · CIK 0002007249
Michael Geffner
Files at IMVT (Immunovant, Inc.). First filing Oct 25, 2024, latest Oct 24, 2025.
Michael Geffner files SEC Form 4 as officer at IMVT (Immunovant, Inc.). Since Oct 25, 2024, Michael Geffner has reported 0 open-market buys worth $0 and 8 open-market sells worth $405k, the latest filed on Oct 24, 2025.
A track record needs three past buys with six months of prices behind them; Michael Geffner has 0, so none is measured yet.
The newest scored trade: sold $49k of IMVT on Oct 22, 2025, filed Oct 24, 2025, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $49k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Immunovant, Inc. | $49k 2,595 shares | -1% | +42% from low-40% from high | |
| 23Weak | Immunovant, Inc. | $21k 1,272 shares | -1% | +21% from low-49% from high | |
| 29Weak | Immunovant, Inc. | $43k 2,385 shares | -1% | +38% from low-41% from high | |
| 23Weak | Immunovant, Inc. | $20k 1,160 shares | -1% | +30% from low-45% from high | |
| 36Weak | Immunovant, Inc. | $35k 2,349 shares | -1% | +9% from low-54% from high | |
| 39Weak | Immunovant, Inc. | $80k 6,169 shares | -3% | +12% from low-53% from high | |
| 38Weak | Immunovant, Inc. | $63k 2,657 shares | -2% | - | |
| 40Moderate | Immunovant, Inc. | $94k 3,189 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 10, 2026 | IMVT IMMUNOVANT, INC. | 5,800 0.00% of outstanding | $155k | Feb 10, 2026 | $3.7M |
| Nov 26, 2025 | IMVT IMMUNOVANT, INC. | 50,000 0.03% of outstanding | $1.2M | Nov 26, 2025 | $2.5M |
| Nov 25, 2025 | IMVT IMMUNOVANT, INC. | 103,897 0.06% of outstanding | $2.4M | Nov 25, 2025 | $70k |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,595 | $19.03 | $49k | 217,958 | Oct 24, 2025 |
| Oct 8, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,272 | $16.30 | $21k | 220,553 | Oct 10, 2025 |
| Jul 23, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,385 | $18.15 | $43k | 221,825 | Jul 25, 2025 |
| Jul 9, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,160 | $17.24 | $20k | 224,210 | Jul 11, 2025 |
| Apr 23, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,349 | $14.79 | $35k | 225,370 | Apr 25, 2025 |
| Apr 9, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -6,169 | $12.99 | $80k | 227,719 | Apr 11, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +101,574 | $0.00 | $0 | 233,888 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +143,063 | $0.00 | $0 | 143,063 | Apr 3, 2025 |
| Jan 22, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,657 | $23.59 | $63k | 132,314 | Jan 24, 2025 |
| Oct 23, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -3,189 | $29.53 | $94k | 134,971 | Oct 25, 2024 |
Questions about Michael Geffner
Answered from the filings on this page, as of the latest one.
Is Michael Geffner buying or selling?
In the last 12 months Michael Geffner reported 0 open-market buys worth $0 and 1 open-market sell worth $49k on SEC Form 4; the latest was sold $49k of IMVT on Oct 22, 2025. Grants, option exercises and tax withholding are not counted.
How did Michael Geffner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Geffner has 0.
Where does Michael Geffner file Form 4?
Michael Geffner has filed Form 4 at IMVT (Immunovant, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.